• N3-kethoxal: Precision RNA Structure Mapping & DNA Accessibi

  2026-04-30

  N3-kethoxal enables high-resolution, membrane-permeable probing of RNA secondary structures and accessible genomic DNA, streamlining click-chemistry workflows in living and fixed cells. Its unique azide functionalization sets it apart from legacy probes, delivering advanced insights into nucleic acid architecture and RNA-protein interactions.

• EV-Transferred ACLY Drives TAM Differentiation in Liver Canc

  2026-04-30

  This study uncovers how hepatocellular carcinoma cells secrete extracellular vesicles containing ATP-citrate lyase, which are taken up by monocytes and drive their transformation into immunosuppressive tumor-associated macrophages (TAMs). Targeting this EV-mediated ACLY transfer offers a mechanistically precise strategy to enhance immunotherapy efficacy in hepatocellular carcinoma.

• Cy5 NHS ester(Et): Technical Guidance for Protein Labeling P

  2026-04-29

  Cy5 NHS ester(Et) enables efficient, water-soluble fluorescent labeling of primary amines in proteins and biomolecules, offering robust detection in immunofluorescence, flow cytometry, and fluorescence microscopy workflows. It is not suitable for ethanol-based protocols or applications requiring extended storage of dye solutions, and should be used promptly in aqueous or DMSO-based setups for optimal results.

• NFIA Regulates Bone Homeostasis via Osteoclast and Osteoblas

  2026-04-29

  This study identifies nuclear factor I/A (NFIA) as a critical regulator of bone homeostasis, demonstrating its dual role in suppressing both osteoclast and osteoblast differentiation through transcriptional modulation. The findings provide new mechanistic insights into age-related bone loss and present novel targets for bone disease research.

• Griseofulvin’s Mechanistic Edge: Strategic Use in Translatio

  2026-04-28

  This thought-leadership article explores the transformative role of Griseofulvin as a microtubule associated inhibitor in antifungal research, blending mechanistic insights with practical guidance for translational scientists. Drawing on recent multi-tiered molecular assays and validated product characteristics, it outlines best protocols, differentiates Griseofulvin’s unique value, and provides a roadmap for leveraging its mechanism for high-impact, reproducible research outcomes.

• ALDH2 Activation Promotes Cardiomyocyte Proliferation in Hea

  2026-04-28

  This study demonstrates that activating ALDH2, particularly through pharmacological means, significantly extends the proliferative window of cardiomyocytes and delays the progression of pressure overload-induced heart failure in mice. The findings establish ALDH2 as a promising therapeutic node for cardiac regeneration, offering new directions for heart failure research.

• Q-VD-OPh: Pan-Caspase Inhibitor Workflows for Apoptosis Rese

  2026-04-27

  Q-VD-OPh stands apart as a potent, irreversible pan-caspase inhibitor, enabling high-fidelity apoptosis research across in vitro and in vivo models. This guide details setup, advanced experimental workflows, and troubleshooting strategies, maximizing data quality in cell death, neurodegeneration, and post-cryopreservation studies.

• NU7441 (KU-57788): Enhancing DNA Repair and Oncology Researc

  2026-04-27

  NU7441 (KU-57788) stands out as a gold-standard DNA-PK inhibitor for dissecting DNA repair mechanisms and sensitizing cancer cells to DNA-damaging agents. Its nanomolar potency, selectivity, and proven application in both oncology and advanced virology workflows make it indispensable for translational research.

• Axon Trafficking Prevents Pathological TIA1 Aggregation in N

  2026-04-26

  This study uncovers a mechanistic link between axonal mRNA transport and the prevention of aberrant protein aggregation in neurons. By identifying Annexin A7 (ANXA7) as a key adaptor for retrograde trafficking of TIA1-containing ribonucleoprotein complexes, the work clarifies how disruptions in this process contribute to neurodegeneration.

• Noncompetitive TRPV1 Antagonism by SAF312 for Ocular Surface

  2026-04-25

  This study characterizes SAF312 (Libvatrep) as a selective, noncompetitive TRPV1 antagonist with robust safety and pharmacologic properties for topical ocular application. The findings support the potential of targeted TRPV1 modulation in treating ocular surface pain without delaying wound healing or causing major adverse effects.

• EdU Flow Cytometry Assay Kits (Cy5): Workflow and QC Guide

  2026-04-24

  EdU Flow Cytometry Assay Kits (Cy5) enable reliable, denaturation-free quantification of S-phase DNA synthesis for cell proliferation studies. This kit is best used in flow cytometry workflows where high sensitivity and compatibility with multiplexed staining are required, but is not recommended for applications needing DNA denaturation or non-Cy5 fluorophores.

• Synthetic Efferocytic Receptors Reprogram Microglia for Anti

  2026-04-24

  This study introduces a synthetic efferocytic receptor (SER) mRNA strategy to reprogram microglia for selective, anti-inflammatory clearance of amyloid-β in Alzheimer’s disease (AD) mouse models. By engineering microglia with mRNA-loaded lipid nanoparticles, the approach achieves efficient Aβ removal with reduced neuroinflammation, offering a promising therapeutic paradigm.

• N3-kethoxal: Precision Mapping of RNA Structures and DNA Acc

  2026-04-23

  N3-kethoxal empowers researchers to probe unpaired guanine bases in RNA and single-stranded DNA with high specificity, enabling structural and interaction studies at unprecedented resolution. Leveraging bioorthogonal click chemistry, this APExBIO probe streamlines workflows for mapping RNA conformations, uncovering genomic DNA accessibility, and elucidating RNA-protein proximity in both in vitro and in vivo settings.

• Fluoroalkane-Modified Polymers Advance mRNA Cancer Vaccines

  2026-04-23

  This study introduces fluoroalkane-grafted polyethylenimine (F-PEI) as a streamlined, effective delivery carrier for mRNA-based personalized cancer vaccines. The approach enhances cytosolic delivery, antigen presentation, and antitumor immune responses, offering a promising alternative to complex lipid nanoparticle systems.

• Disulfidptosis-Driven Immune Modeling and c-MET’s Role in T

  2026-04-22

  This study introduces a pan-cancer immune response prediction model based on disulfidptosis signatures, leveraging artificial intelligence to stratify prognosis and therapy response, particularly in glioma. Experimental validation highlights c-MET as a key regulator of T cell exhaustion, providing mechanistic insights for translational oncology and immunotherapy research.

16088 records 1/1073 page Next 12345 下5页 Last page